FLT-3: a new focus in the understanding of acute leukemia-Reference-Cited by-同舟云学术

FLT-3: a new focus in the understanding of acute leukemia

Published:2005-06 Issue:6 Volume:37 Page:1168-1172
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Markovic Ana,MacKenzie Karen L.,Lock Richard B.

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference21 articles.

1. Inhibition of FLT3 in MLL: validation of a therapeutic target identified by gene expression based classification;Armstrong;Cancer Cell,2003

2. A phase I study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease;Fiedler;Blood (First Edition Paper),2004

3. SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes;Giles;Blood,2003

4. The roles of FLT3 in hematopoiesis and leukemia;Gilliland;Blood,2002

5. Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes;Karlsson;Journal of Leukocyte Biology,2003

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of NPM1 and FLT3 Mutations in Patients with Acute Myeloid Leukemia in Jeddah, Saudi Arabia: A Pilot Study;International Journal of Biomedicine;2023-03-03

2. Sunitinib-based Proteolysis Targeting Chimeras (PROTACs) reduced the protein levels of FLT-3 and c-KIT in leukemia cell lines;Bioorganic & Medicinal Chemistry Letters;2022-12

3. FLT3 Gene Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand;Medical Science Monitor Basic Research;2022-11-24

4. 4-Aminopyrazolopyrimidine scaffold and its deformation in the design of tyrosine and serine/threonine kinase inhibitors in medicinal chemistry;RSC Medicinal Chemistry;2022

5. RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients;Saudi Journal of Biological Sciences;2021-09